Aristotle University Of Thessaloniki (AUTH)
Μελέτη της θεραπευτικής δράσης της τοσιλιζουμάμπης σε πειραματικό μοντέλο αρθρίτιδας νεαρών επίμυων και η δράση αυτής στην οστική πυκνότητα και τις τενόντιες δομές
Abstract
dc:descriptionReduced Bone Mineral Density (BMD) is a prevalent comorbidity in Juvenile Idiopathic Arthritis (JIA). Enthesitis and other tendon abnormalities, such as tenosynovitis, tendinitis and tendon ruptures are, also, common extra-articular manifestations of the disease. The aim of the present study was to investigate the effect of tocilizumab, an antibody that binds the Interleukin-6 (IL-6) Receptor, on inflammation-related bone loss and tendon inflammation in an animal model of JIA. In the present study, 155, male, 6-8-week-old, Wistar rats were used. The Collagen-Induced Arthritis (CIA) model was induced in 120 of them. Rats received tocilizumab intraperitoneally for 8 weeks. Methotrexate, the most widely used Disease-Modifying Antirheumatic Drug in the management of JIA, and infliximab, an antibody against Tumor Necrosis Factor-a (TNF-a) were, also, administered. BMD was evaluated with Micro-Computed Tomography (Micro-CT) and histopathological examination. Tendon damage was, also, assessed histologically. Finally, two pro-inflammatory cytokines, Tumor Necrosis Factor- alpha (TNF-a) and Interleukin-23 (IL-23), were quantified in tendon tissues by ELISA analysis. Tocilizumab had no effect on the bone and tendon morphology of the healthy animals. Regarding arthritic animals, the tocilizumab-treated exhibited a significantly improved trabecular microarchitecture on micro-CT analysis and histological examination. Tendon morphology was, also, improved. Anti-IL-6 treatment led to a significant decrease in TNF-a and IL-23 expression in tendon tissue. Infliximab had a similar effect but to a lower extent. The results of the present study provide evidence that tocilizumab reduces inflammation-related bone loss and suppresses tendon inflammation in a juvenile CIA rat model. These findings offer perspectives for the management of osteoporosis and enthesitis in JIA.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Poutoglidou, Freideriki
- Πουτογλίδου, Φρειδερίκη
Subjects
dc:subject × 18- Τοσιλιζουμάμπη
- Κολλαγονο-Επαγόμενη Αρθρίτιδα
- Οστική πυκνότητα
- Φλεγμονή τενόντων
- Tocilizumab
- Collagen-induced arthritis
- Bone mineral density
- Tendon inflammation
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Φαρμακολογία και Φαρμακευτική
- Κλινική Ιατρική
- Ορθοπεδική και Αθλιατρική
- Basic Medicine
- Medical and Health Sciences
- Pharmacology and Pharmacy
- Clinical Medicine
- Orthopedics and Sports Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/50656